Previous 10 | Next 10 |
New study design is more highly powered with improved patient selection criteria to better assess the primary efficacy endpoint Positive results could support a marketing application for new U.S. stress urinary incontinence indication ENGLEWOOD, CO / ACCESSWIRE / January 21, 2021...
Viveve Medical (VIVE) upsizes underwritten public offering of units for gross proceeds of approximately $27.6M.It is priced at a public offering price of $3.40 per Class A Unit.A.G.P./Alliance Global Partners acted as the sole book-running managePress Release For further details see: ...
ENGLEWOOD, CO / ACCESSWIRE / January 19, 2021 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced the closing of an upsized underwritten public offering of units for gross proceeds of approximately $27.6 million, w...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning. on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks finished lower Friday, as optimism over President-elect Biden's proposed $1.9 trillion stimulus plan gave way to questions around bip...
Gainers: Datasea (DTSS) +90%.Lexicon Pharmaceuticals (LXRX) +85%.Pennsylvania Real Estate Investment Trust (PEI) +50%.DPW Holdings (DPW) +36%.Organogenesis (ORGO) +34%.Acacia Communications (ACIA) +33%.Bicycle Therapeutics (BCYC) +31%.AeroVironment (AVAV) +29%.Maxar Technologie...
Gainers: Organogenesis Holdings (ORGO) +33%. Lexicon Pharmaceuticals (LXRX) +30%. NantKwest (NK) +27%. Oragenics (OGEN) +25%. Bicycle Therapeutics (BCYC) +23%.Losers: Viveve Medical (VIVE) -23%. Cassava Sciences (SAVA) -12%. Timber Pharmaceuticals (TMBR) -11%. InflaRx N.V. (IFRX) -9...
Viveve Medical (VIVE) prices its upsized public offering of units for gross proceeds of ~$24M.Offering is comprised of 4,607,940 Class A common shares at $3.40/share, each unit consisting of one share of common stock and one warrant to purchase one share of common sto...
Volt Information Sciences VOLT -17% erasing yesterday's gains post Q4 results.Live Ventures LIVE -12% erasing yesterday's gains post FY results.Takung Art (TKAT) -11%.Nano Dimension NNDM -10% after prices $332.5M direct offering.Viveve Medical (VIVE) -1...
ENGLEWOOD, CO / ACCESSWIRE / January 14, 2021 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced the pricing of an upsized underwritten public offering of units for gross proceeds of approximately $24 Million (or ...
InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite treatment, and more. InMode is an asset-light business with high returns on capital and a flawles...
News, Short Squeeze, Breakout and More Instantly...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-12-31 MedAvail Holdings Inc. (MDVL) is expected to report for Q3 2023 Nobility Homes, Inc. (NOBH) is expected to report for quarter end 2023-10-31 Walgreens Boots Alliance Inc. (WBA) is expected to report $0.66 for Q1 ...
Disco Corporation ADR (DSCSY) is expected to report for Q2 2024 Sonic Foundry Inc. (SOFO) is expected to report for quarter end 2023-09-30 Sono Group N.V. (SEVCQ) is expected to report for quarter end 2023-09-30 Minim Inc (MINM) is expected to report for Q3 2023 Enel Spa ADR (ENLA...
Enel Spa ADR (ENLAY) is expected to report for Q3 2023 LEG Immobilien SE Registered Shares (LEGIF) is expected to report for Q3 2023 G. Willi-Food International Ltd. (WILC) is expected to report for Q3 2023 Worthington Steel Inc. (WS) is expected to report $0.15 for Q2 2024 Sonic ...